Last visit was: 06 May 2024, 21:30 |
It is currently 06 May 2024, 21:30 |
School
|
Name
|
Status
|
Round
|
Date
|
GMAT Focus
GMAT
GRE
|
Nationality
|
WE
|
GPA
|
Post-MBA industry
|
Year
|
---|---|---|---|---|---|---|---|---|---|---|
IESE Full Time MBA |
Admitted | Round 2 | Mar 30 2023 08:11 PM |
690 GMAT Classic | India | 4.3 years |
4 | Consulting | 2023 | |
IESE Full Time MBA |
Denied with Interview | Round 2 | Mar 28 2023 03:29 AM |
740 GMAT Classic | Uzbekistan | 3 years |
3.3 | Other | 2023 | |
IESE Full Time MBA |
Waitlisted with Interview | Round 2 | Mar 28 2023 02:21 AM |
610 GMAT Classic | India | 5.6 years |
4 | 2023 | ||
IESE Full Time MBA |
Admitted | Round 2 | Mar 27 2023 01:08 PM |
680 GMAT Classic | India | 6.1 years |
4 | Consulting | 2023 | |
IESE Full Time MBA |
Invited to Interview | Round 3 | Mar 26 2023 10:20 AM |
690 GMAT Classic | India | 2023 | ||||
IESE Full Time MBA |
Admitted | Round 2 | Mar 25 2023 04:46 AM |
319 GRE | Saudi Arabia | 0 year |
3.93 | 2023 | ||
IESE Full Time MBA |
Invited to Interview | Round 3 | Mar 24 2023 11:04 AM |
760 GMAT Classic 760 GMAT Classic |
India | 7 years |
2023 | |||
IESE Full Time MBA |
Denied with Interview | Round 2 | Mar 23 2023 09:27 AM |
690 GMAT Classic | India | 7 years |
3.63 | Consulting | 2023 | |
IESE Full Time MBA |
Admitted | Round 2 | Mar 21 2023 11:26 AM |
155 EA | India | 18.5 years |
3.41 | 2023 | ||
IESE Full Time MBA |
Female
|
Denied with Interview | Round 2 | Mar 21 2023 05:33 AM |
650 GMAT Classic | India | 8.5 years |
3.53 | Health Care | 2023 |
IESE Full Time MBA |
Admitted | Round 2 | Mar 21 2023 12:48 AM |
650 GMAT Classic | Malaysia | 5.4 years |
3.31 | 2023 | ||
IESE Full Time MBA |
Admitted | Round 2 | Mar 20 2023 05:50 PM |
Mexico | 0 year |
2023 | ||||
IESE Full Time MBA |
Admitted | Round 2 | Mar 20 2023 11:55 AM |
Nigeria | 7.8 years |
3.2 | Consulting | 2023 | ||
IESE Full Time MBA |
Admitted | Round 2 | Mar 20 2023 11:33 AM |
700 GMAT Classic | Chile | 6 years |
2023 | |||
IESE Full Time MBA |
Admitted | Round 2 | Mar 20 2023 08:04 AM |
Australia | 9.3 years |
3.53 | Pharmaceuticals and Biotech | 2023 | ||
IESE Full Time MBA |
Admitted | Round 2 | Mar 20 2023 06:39 AM |
China | 7.6 years |
2023 | ||||
IESE Full Time MBA |
Admitted | Round 2 | Mar 18 2023 02:38 PM |
680 GMAT Classic | Spain | 6 years |
3.1 | 2023 | ||
IESE Full Time MBA |
Admitted | Round 2 | Mar 17 2023 11:29 AM |
335 GRE | United States | 6 years |
2.98 | 2023 | ||
IESE Full Time MBA |
Admitted | Round 2 | Mar 16 2023 03:54 PM |
319 GRE | United States | 5 years |
3.19 | 2023 | ||
IESE Full Time MBA |
Admitted | Early Decision | Mar 15 2023 12:11 AM |
710 GMAT Classic 328 GRE 169 EA 169 EA 169 EA |
India | 5.5 years |
3.59 | 2023 |